Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail
-

Interferon beta-1a Product Approval Information - Licensing Action 5/17/96

Proper name: Interferon beta-1a
Tradename: Avonex
Manufacturer: Biogen, Inc, Cambridge, MA, License #1204 
Indication for Use: Treatment of relapsing forms of multiple sclerosis to slow the accumulation of physical disability and decrease the frequency of clinical exacerbations
Approval Date: 5/17/96
Type of submission: Product license application

 

Approval Letter (PDF)

Label (PDF)

SBA (PDF)

-
-